Net profit of Concord Biotech declined 15.07% to Rs 64.48 crore in the quarter ended December 2025 as against Rs 75.92 crore during the previous quarter ended December 2024. Sales rose 13.74% to Rs 277.77 crore in the quarter ended December 2025 as against Rs 244.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales277.77244.22 14 OPM %35.3840.11 - PBDT108.18114.42 -5 PBT89.44101.15 -12 NP64.4875.92 -15 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Concord Biotech declined 33.59% to Rs 63.58 crore in the quarter ended September 2025 as against Rs 95.74 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales247.06310.18 -20 OPM %35.8243.11 - PBDT104.08143.65 -28 PBT85.68130.34 -34 NP63.5895.74 -34 Powered by Capital Market - Live News

Net profit of Concord Biotech declined 36.27% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 98.70 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales247.06310.18 -20 OPM %36.6544.06 - PBDT103.92146.60 -29 PBT85.53133.29 -36 NP62.9098.70 -36 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News